Xpert Perspectives on IBS from ACG/WCOG in Orlando

Viewing Options


Topic Information

Goal Statement

The primary goal of the educational activities is to encourage the application of the latest advances in evidence-based medicine to achieve improved outcomes for the patients affected by IBS.

Target Audience

The live meeting series will target gastroenterologists, physician assistants, and nurse practitioners involved in the diagnosis and management of IBS.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Discuss evidence-based treatment plans for patients with IBS-D effectively into practice

Explain evidence-based treatment plans for patients with IBS-C and CIC effectively into practice

Incorporate evidence-based treatment plans for OEC effectively into clinical practice

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Cincinnati and the GI Health Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: November 21st, 2017
Expiration Date: November 21st, 2018   
*This program has expired. CME credit is no longer available.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, GI Health Foundation staff and the University of Cincinnati staff have no relationships to disclose.

Consultant/ Honorarium: Allergan, Biomerica, IM Health, Ironwood, Nestle, Salix, Prometheus
Patent Holder: My GI Health, My Nutrition Health
Research Grants: Nestle, Ardelyx, Vibrant

Advisory Board: Ironwood

Research Grants: Valeant
Consultant/Honorarium: Valeant, Commonwealth, Naia, Synthetic Biologics
Speaker Bureau: Valeant
Advisory Board Membership: Valeant, Commonwealth, Naia, Synthetic Biologics
Stockholder: Naia, Synthetic Biologics
Editorial Board Involvement: American Journal and Gastroenterology
Other: Cedars Sinai has licensing agreement with the 4 companies list above

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This activity is supported by educational grants from Allergan, Inc., Commonwealth Diagnostics International, Inc., Ironwood Pharmaceuticals, Inc., and Salix Pharmaceuticals.

Provided by:

Accredited by

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.